Latest filing published 05 Mar 2019 for Asterias Biotherapeutics, Inc..
Ryan Daniel Chavez discloses dealings in Asterias Biotherapeutics, Inc. to SEC (Form 4). In total, 9 filings cover trades dated from 30 March 2017 to 1 March 2019.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 5 March 2019 with a share grant in Asterias Biotherapeutics, Inc. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations